910 related articles for article (PubMed ID: 20338394)
1. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism.
Patel CN; Salahudeen HM; Lansdown M; Scarsbrook AF
Clin Radiol; 2010 Apr; 65(4):278-87. PubMed ID: 20338394
[TBL] [Abstract][Full Text] [Related]
2. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
[TBL] [Abstract][Full Text] [Related]
3. Preoperative ⁹⁹mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging.
Shafiei B; Hoseinzadeh S; Fotouhi F; Malek H; Azizi F; Jahed A; Hadaegh F; Salehian M; Parsa H; Javadi H; Assadi M
Nucl Med Commun; 2012 Oct; 33(10):1070-6. PubMed ID: 22825041
[TBL] [Abstract][Full Text] [Related]
4. Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT and Multiphase Multidetector 4D CT.
Vu TH; Schellingerhout D; Guha-Thakurta N; Sun J; Wei W; Kappadth SC; Perrier N; Kim EE; Rohren E; Chuang HH; Wong FC
AJNR Am J Neuroradiol; 2019 Jan; 40(1):142-149. PubMed ID: 30523145
[TBL] [Abstract][Full Text] [Related]
5. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
Lorberboym M; Minski I; Macadziob S; Nikolov G; Schachter P
J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
[TBL] [Abstract][Full Text] [Related]
6. Clinical Value of Tc99m-MIBI SPECT/CT Versus 4D-CT or US in Management of Patients With Hyperparathyroidism.
Kedarisetty S; Fundakowski C; Ramakrishnan K; Dadparvar S
Ear Nose Throat J; 2019 Mar; 98(3):149-157. PubMed ID: 30938239
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ultrasonography and Tc-99m MIBI SPECT/CT in preoperative localization of parathyroid adenomas causing primary hyperthyroidism.
Lu R; Zhao W; Yin L; Guo R; Wei B; Jin M; Zhou X; Zhang C; Lv X
BMC Med Imaging; 2021 May; 21(1):87. PubMed ID: 34020602
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
Billy HT; Rimkus DR; Hartzman S; Latimer RG
Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
[TBL] [Abstract][Full Text] [Related]
9. Preoperative 4D CT Localization of Nonlocalizing Parathyroid Adenomas by Ultrasound and SPECT-CT.
Hinson AM; Lee DR; Hobbs BA; Fitzgerald RT; Bodenner DL; Stack BC
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):775-8. PubMed ID: 26248963
[TBL] [Abstract][Full Text] [Related]
10. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism.
Krausz Y; Bettman L; Guralnik L; Yosilevsky G; Keidar Z; Bar-Shalom R; Even-Sapir E; Chisin R; Israel O
World J Surg; 2006 Jan; 30(1):76-83. PubMed ID: 16369710
[TBL] [Abstract][Full Text] [Related]
12. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
13. Cystic parathyroid adenoma: sonographic features and correlation with 99mTc-sestamibi SPECT findings.
Johnson NA; Yip L; Tublin ME
AJR Am J Roentgenol; 2010 Dec; 195(6):1385-90. PubMed ID: 21098199
[TBL] [Abstract][Full Text] [Related]
14. Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy.
Schachter PP; Issa N; Shimonov M; Czerniak A; Lorberboym M
Arch Surg; 2004 Apr; 139(4):433-7. PubMed ID: 15078713
[TBL] [Abstract][Full Text] [Related]
15. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism.
Yeh R; Tay YD; Tabacco G; Dercle L; Kuo JH; Bandeira L; McManus C; Leung DK; Lee JA; Bilezikian JP
Radiology; 2019 May; 291(2):469-476. PubMed ID: 30835187
[TBL] [Abstract][Full Text] [Related]
17. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
Neumann DR; Obuchowski NA; Difilippo FP
J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
[TBL] [Abstract][Full Text] [Related]
18. Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease.
Katz SC; Wang GJ; Kramer EL; Roses DF
Am Surg; 2003 Feb; 69(2):170-5. PubMed ID: 12641362
[TBL] [Abstract][Full Text] [Related]
19. Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter.
Lorberboym M; Ezri T; Schachter PP
Arch Surg; 2005 Jul; 140(7):656-60. PubMed ID: 16027330
[TBL] [Abstract][Full Text] [Related]
20. Preoperative [
Keidar Z; Solomonov E; Karry R; Frenkel A; Israel O; Mekel M
Mol Imaging Biol; 2017 Apr; 19(2):265-270. PubMed ID: 27704321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
